Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ERLOTINIB vs ERTUGLIFLOZIN PIDOLATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ERLOTINIB vs ERTUGLIFLOZIN PIDOLATE: Safety Overview

Metric ERLOTINIB ERTUGLIFLOZIN PIDOLATE
Total FAERS Reports 22,472 681
Deaths Reported 6,791 4
Death Rate 30.2% 0.6%
Hospitalizations 3,693 128
Average Patient Age 67.2 yrs 57.0 yrs
% Female Patients 59.8% 56.1%
FDA Approval Date Apr 16, 2020 N/A
Manufacturer Zydus Lifesciences Limited Merck Sharp & Dohme LLC
Route ORAL ORAL
Marketing Status Discontinued N/A